AMD
Advanced Micro Devices, Inc.
AMD has the edge over CREX overall, supported by stronger fundamentals and stronger modeled upside.
CREX
Creative Realities, Inc.
CREX's outlook is improving, though it still trails on the overall score.
AMD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
AMD's revenue, profitability, cash flow and balance sheet are all currently strong.
CREX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Stable |
CREX's revenue is currently strong, and its balance sheet is stable, but its profitability and cash flow are weak.
AMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 39x | $585 | — |
| Cheap | 40x | $182 | -69% |
| Fair | 112x | $514 | -12% |
| Current | 127x | $585 | — |
| Expensive | 206x | $947 | +62% |
Historical ranges are pointers, not guarantees.
AMD's PE is in its fair range at 127x. If earnings grow as analysts expect, today's price would be 39x next year's earnings, in its cheap range.
CREX PE Valuation
CREX has no meaningful PE right now: it lost money over the past year.
AMD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect strong earnings and revenue growth for AMD, with profitability improving. However, they disagree widely on these estimates.
CREX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CREX's losses to shrink, with revenue growing.
AMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $15.05 | +227% |
| Q3 2026 | $4.60 | +127% |
| Q2 2026 | $3.89 | +122% |
| Q1 2026 | $3.05 | +123% |
| Q4 2025 | $2.65 | +165% |
| Q3 2025 | $2.03 | +81% |
| Q2 2025 | $1.75 | +111% |
| Q1 2025 | $1.37 | +99% |
| Q4 2024 | $1.00 | +89% |
AMD has the edge over CREX on earnings quality, reporting a profit while its opponent remains loss making.
CREX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.11 | -$1.99 |
| Q1 2026 | -$1.87 | -$1.86 |
| Q4 2025 | -$0.81 | -$0.47 |
| Q3 2025 | -$0.88 | -729% |
| Q2 2025 | -$0.12 | -$0.03 |
| Q1 2025 | -$0.01 | +$0.21 |
| Q4 2024 | -$0.34 | +$0.01 |
| Q3 2022 | $0.15 | -55% |
CREX is still losing money, but far less than before: $2.11 per share over the past year, against $5.16 at its worst in late 2020.
AMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13.4B | +45% |
| Q2 2026 | $11.5B | +50% |
| Q1 2026 | $10.3B | +38% |
| Q4 2025 | $10.3B | +34% |
| Q3 2025 | $9.2B | +36% |
| Q2 2025 | $7.7B | +32% |
| Q1 2025 | $7.4B | +36% |
| Q4 2024 | $7.7B | +24% |
AMD has the edge over CREX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +7.4 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 14% | +3.6 points |
| Q4 2025 | 17% | +5.7 points |
| Q3 2025 | 14% | +3.1 points |
| Q2 2025 | -1.7% | -6.4 points |
| Q1 2025 | 11% | +10 points |
| Q4 2024 | 11% | +5.8 points |
AMD has the edge over CREX on profitability, with a higher operating margin.
CREX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $21.5M | +65% |
| Q1 2026 | $16.3M | +68% |
| Q4 2025 | $23.9M | +117% |
| Q3 2025 | $10.5M | -27% |
| Q2 2025 | $13M | -0.6% |
| Q1 2025 | $9.7M | -21% |
| Q4 2024 | $11M | -24% |
| Q3 2024 | $14.4M | +25% |
CREX's revenue is recovering but still below its 2022 peak: $22M last quarter, up 65% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -13% | -2.5 points |
| Q1 2026 | -38% | -31 points |
| Q4 2025 | 1.9% | +8.4 points |
| Q3 2025 | -69% | -77 points |
| Q2 2025 | -10% | -15 points |
| Q1 2025 | -7.4% | -6.8 points |
| Q4 2024 | -6.5% | -20 points |
| Q3 2024 | 7.9% | +6.5 points |
CREX's operating margin was −13% last quarter, down 2.5 points from the same quarter a year ago.
AMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $554M | -71% |
| Q2 2026 | $1.6B | -9.9% |
| Q1 2026 | $2.6B | +253% |
| Q4 2025 | $2.4B | +118% |
| Q3 2025 | $1.9B | +283% |
| Q2 2025 | $1.7B | +294% |
| Q1 2025 | $727M | +92% |
| Q4 2024 | $1.1B | +351% |
AMD has the edge over CREX on cash generation, producing positive trailing cash flow while its opponent burns cash.
CREX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $457K | -32% |
| Q1 2026 | -$1.9M | +$551K |
| Q4 2025 | -$7M | -$5.6M |
| Q3 2025 | -$1.7M | -415% |
| Q2 2025 | $672K | -70% |
| Q1 2025 | -$2.5M | -227% |
| Q4 2024 | -$1.4M | +$1.8M |
| Q3 2024 | $543K | -71% |
CREX's free cash flow was −$10M over the past year, against −$3M the year before.
AMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +2M shares |
| 1 year | +1.2% | +20M shares |
| 3 years | +2% | +32M shares |
| 5 years | +35% | +431M shares |
| Available history | +40% | +473M shares |
AMD has 1.7B diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $221M |
| Q4 2025 | — |
| Q3 2025 | $89M |
| Q2 2025 | $478M |
| Q1 2025 | $749M |
| Q4 2024 | $256M |
AMD has spent almost nothing on buybacks in the past year.
CREX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +16K shares |
| 1 year | +1.2% | +121K shares |
| 3 years | +44% | +3.2M shares |
| 5 years | +211% | +7.2M shares |
CREX has the edge over AMD on shareholder dilution, with a more favorable share count trend.
AMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2020 | -1.0x | Net Cash |
| Q1 2020 | -0.8x | Net Cash |
| Q4 2019 | -1.2x | Net Cash |
AMD has more cash than debt.
CREX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2024 | 2.1x | Moderate |
| Q4 2023 | 2.3x | Moderate |
| Q3 2023 | 4.8x | High |
| Q2 2023 | 13.2x | High |
| Q1 2023 | 10.0x | High |
| Q4 2022 | 45.2x | High |
| Q4 2019 | 4.9x | High |
CREX's net debt is about 2.1 years of its operating earnings (EBITDA), down from 10 years a year ago.
AMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.3 | Neutral |
| Stochastic | 41.4 | Neutral |
AMD's weekly RSI is 59 (neutral) and its Stochastic is 41 (neutral).
CREX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 8.9 | Oversold |
CREX's weekly RSI is 33 (neutral) and its Stochastic is 9 (oversold).
AMD PE vs Technology Sector
| Metric | AMD | Sector median | Relative |
|---|---|---|---|
| PE | 127x | 28x | 357% above |
| PE % | 61 | 35 | 26 pts above |
AMD is trading at 127x earnings, a 357% premium to the Technology sector's median of 28x.
CREX PE vs Technology Sector
| Metric | CREX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CREX has no meaningful PE right now: it lost money over the past year.
AMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $557.2 | 5.1% above |
| 20 week MA | $525.9 | 11% above |
| 50 week MA | $389.7 | 50% above |
| 100 week MA | $266.9 | 119% above |
| 200 week MA | $199.6 | 193% above |
AMD has the edge over CREX on trend strength, trading above more of its moving averages.
CREX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.25 | 4.4% below |
| 20 week MA | $2.79 | 23% below |
| 50 week MA | $3.20 | 33% below |
| 100 week MA | $2.87 | 25% below |
| 200 week MA | $2.98 | 28% below |
CREX is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.
AMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.2 | $91.8 | +99% |
| 2021 | $91.8 | $146.1 | +59% |
| 2022 | $146.1 | $64.5 | -56% |
| 2023 | $64.5 | $147.4 | +128% |
| 2024 | $147.4 | $125.2 | -15% |
| 2025 | $125.2 | $215.0 | +72% |
| 2026 YTD | $215.0 | $585.3 | +172% |
AMD has the edge over CREX on returns for 2026, with the stronger performance.
CREX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.20 | $3.90 | -7.1% |
| 2021 | $3.90 | $4.38 | +12% |
| 2022 | $4.38 | $1.71 | -61% |
| 2023 | $1.71 | $2.36 | +38% |
| 2024 | $2.36 | $2.69 | +14% |
| 2025 | $2.69 | $2.66 | -1.1% |
| 2026 YTD | $2.66 | $2.15 | -19% |
CREX has finished lower in three of the last six years. It's down 19% so far in 2026.